NCT05704985 2025-05-29
Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
DEKA Biosciences
Phase 1 Active not recruiting
DEKA Biosciences
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
National Cancer Institute (NCI)
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Fox Chase Cancer Center